Fas expression and function in normal and malignant breast cell lines

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4791-4798

  Keane, Maccon M ^a   Ettenberg, Seth A ^a   Lowrey, Geoffrey A ^a   Russell, Edward K ^a   Lipkowitz, Stan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CASPASE 1; CYSTEINE ENDOPEPTIDASES; ENZYME INDUCTION; FEMALE; HUMANS; INTERFERON TYPE II; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029817663     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Osborne, M. P. Breast development and anatomy. In: J. R. Harris, S. Hellman, I. C. Henderson, and D W. Kinne (eds.), Breast Diseases, Ed. 2, pp. 1-13 Philadelphia: J B. Lippincott Company, 1991.
2. Ferguson, D. J., and Anderson, T J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast Br. J. Cancer, 44: 177-181, 1981.
3. Ferguson, D. J., and Anderson, T. J. Ultrastructural observations on cell death by apoptosis in the resting human breast. Virchows Arch. [Pathol. Anat.], 393: 193-203, 1981.
4. Anderson, T J., Ferguson, D. J., and Raab, G. M. Cell turnover in the resting human breast: influence of parity, contraceptive pill, age and laterality. Br. J. Cancer, 46: 376-382, 1982.
5. Battersby, S., and Anderson, T. J Proliferative and secretory activity in the pregnant and lactating human breast. Virchows Arch. A. Pathol. Anal. Histopathol., 413: 189-196, 1988
6. Tenniswood, M. P., Guenette, R. S., Lakins, J , Mooibroek, M., Wong, P., and Welch, J E Active cell death in hormone-dependent tissues. Cancer Metastasis Rev., 11: 197-220, 1992.
7. Walker, N. I , Bennett, R E., and Kerr, J. F. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185: 19-32, 1989.
8. Warri, A. M., Huovinen, R. L., Laine, A. M., Martikainen, P. M., and Harkonen, P. L. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro J. Natl Cancer Inst., 85: 1412-1418, 1993.
9. Pagliacci, M. C., Tognellini, R , Grignani, F , and Nicoletti, I. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 205-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology, 129: 2555-2562, 1991.
10. Kypnanou, N., English, H. F., Davidson, N. E., and Isaacs, J T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res , 51: 162-166, 1991
11. Bitonti, A. J , Dumont, J. A , Bush, T. L., Cashman, E. A., Cross, D. D., Wright, P. S., Matthews, D. P., McCarthy, J. R , and Kaplan, D. A Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res , 54: 1485-1490, 1994.
12. 2+ concentration and DNA fragmentation. Cancer Res., 52 1342-1346, 1992.
13. Armstrong, D. K , Kaufmann, S H., Ottaviano, Y. L., Furuya, Y., Buckley, J. A , Isaacs, J. T., and Davidson, N. E. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res , 54: 5280-5283, 1994.
14. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K , Bruderlein, S., Henne, C., Schmidt, A., Debatin, K M., Krammer, P H., and Moller, P. Constitutive and induced expression of apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and malignant cells Lab Invest., 69: 415-429, 1993.
15. Hockenbery, D. M , Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad Sci USA, 88: 6961-6965, 1991.
16. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis Science (Washington DC), 245 301-305, 1989
17. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp. Med., 169: 1747-1756, 1989.
18. Dhein, J., Daniel, P. T , Trauth, B. C , Oehm, A , Moller, P , and Krammer, P. H. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J Immunol , 149: 3166-3173, 1992
19. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li, W M., Richards, S., Dhein, J., Trauth, B. C., Ponsting, H , and Krammer, P H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily Sequence identity with the Fas antigen. J. Biol. Chem., 267: 10709-10715, 1992.
20. Itoh, N , Yonehara, S , Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M , Hase, A , Seto, Y , and Nagata, S The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66: 233-243, 1991
21. Soule, H D., Maloney, T. M , Wolman, S R., Peterson, W J , Brenz, R., McGrath, C. M , Russo, J., Pauley, R. J., Jones, R. F , and Brooks, S C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res , 50: 6075-6086, 1990.
22. Stampfer, M. R , and Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzopyrene. Proc Natl. Acad Sci. USA, 82: 2394-2398, 1985.
23. Engel, L. W., Young, N. A., Tralka, T. S., Lippman, M. E , O'Brien, S. J , and Joyce, M. J Establishment and characterization of three new continuous cell lines derived from human breast carcinomas Cancer Res., 38: 3352-3364, 1978.
24. Engel, L. W , and Young, N. A. Human breast carcinoma cells in continuous culture: a review. Cancer Res , 38: 4327-4339, 1978.
25. Cailleau, R., Olive, M., and Cruciger, Q. V Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro, 14: 911-915, 1978.
26. Cailleau, R , Young, R., Olive, M., and Reeves, W. J , Jr Breast tumor cell lines from pleural effusions. J. Natl. Cancer. Inst., 53: 661-674, 1974.
27. Trempe, G , and Fogh, J Variation in characteristic of human tumor cell lines derived from similar tumors. In Vitro, 8: 433-435, 1973.
28. Soule, H D., Vazguez, J , Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
29. Carmichael, J , DeGraff, W. G., Gazdar, A. F., Minna, J. D , and Mitchell, J. B. Evaluation of a tetrazohum-based semiautomated colorimetric assay: assessment of radiosensitivity Cancer Res , 47: 943-946, 1987.
30. Ben-Sasson, S A., Sherman, Y., and Gavrieli, Y. Identification of dying cells: in situ staining. Methods Cell Biol., 46: 29-39, 1995.
31. Memon, S. A., Petrak, D., Moreno, M. B., and Zacharchuk, C. M A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods, 180: 15-24, 1995.
32. Buffone, G J , and Darlington, G J. Isolation of DNA from biological specimens without extraction with phenol. Clin. Chem., 31: 164-165, 1985.
33. Davis, L. G , Dibner, M. D., and Battey, J F Basic Methods in Molecular Biology, Ed 1., pp. 143-146. New York. Elsevier Science Publishing Co., 1986.
34. Alnemri, E S., Fernandes-Alnemri, T., and Litwack, G. Cloning and expression of four novel isoforms of human interleukin-1 β converting enzyme with different apoptotic activities. J Biol. Chem., 270: 4312-4317, 1995.
35. Owen-Schaub, L B , Meterissian, S , and Ford, R. J Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin J. Immunother., 14: 234-241, 1993.
36. Owen-Schaub, L B., Radinsky, R., Kruzel, E., Berry, K , and Yonehara, S Anti-Fas on nonhematopoietic tumors levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54: 1580-1586, 1994
37. Duan, H., Chinnaiyan, A. M., Hudson, P. L. Wing, J. P., He, W. W., and Dixit, V. M ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis J Biol. Chem., 271: 1621-1625, 1996
38. Enan, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis Nature (Lond ), 375: 78-81, 1995
39. Kuida, K., Lippke, J A., Ku, G., Harding, M. W., Livingston, D. J., Su, M S., and Flavell, R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 β converting enzyme. Science (Washington DC), 267: 2000-2003, 1995
40. Los, M., Van de Craen, M., Penning, L C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
41. Tewari, M and Dixit, V. M Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270 3255-3260, 1995.
42. Chinnaiyan, A. M , O'Rourke, K., Tewari, M , and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apopiosis. Cell, 81: 505-512, 1995.
43. Chiou, S K., Tseng, C. C., Rao, L., and White, E. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells J. Virol., 68: 6553-6566, 1994.
44. Itoh, N., Tsujimoto, Y. and Nagata, S Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol., 151: 621-627, 1993
45. Jaattela, M., Benedict, M., Tewari, M , Shayman, J A., and Dixit, V. M Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
46. Lacronique, V , Mignon, A , Fabre, M., Viollet, B., Rouquet, N., Molina, T., Porteu, A., Henrion, A , Bouscary, D., Varlet, P , Joulin, V., and Kahn, A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med., 2: 80-86, 1996.
47. Schroter, M , Lowin, B., Borner, C., and Tschopp, J. Regulation of Fas(Apo-1/ CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Eur J. Immunol , 25: 3509-3513, 1995.
48. Sato T, Irie, S., Kitada, S , and Reed, J C. FAP-1 a protein tyrosine phosphatase that associates with Fas Science (Washington DC), 268: 411-415, 1995.
49. Stanger, B. Z., Leder, P , Lee, T. H., Kim, E., and Seed, B RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81: 513-523, 1995
50. Weller, M , Malipiero, U , Aguzzi, A., Reed, J. C., and Fontana, A Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest , 95: 2633-2643, 1995
51. Henkart, P A. ICE family proteases mediators of all apoptotic cell death? Immunity, 4: 195-201, 1996
52. Thornberry, N A , Bull, H G., Calaycay, J. R , Chapman, K. T., Howard, A. D , Kostura, M. J., Miller, D K , Molineaux, S M , Weidner, J R , Aunins, J , Elliston, K. O., Ayala, J. M., Casano, F. J , Chin, J , Ding, G. J., Egger, L. A , Gaffney, E. P , Limjuco, G , Palyha, O C., Raju, S M., Rolando, A. M., Salley, J P , Yamin, T., Lee, T D., Shively, J. E , MacCross, M., Mumford, R. A., Schmidt, J A., and Tocci, M. J. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature (Lond ), 356: 768-774, 1992.
53. Milligan, C. E., Prevette, D , Yaginuma, H., Homma, S., Cardwell, C., Fritz, L. C., Tomaselli, K. J., Oppenheim, R. W., and Schwartz, L M. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron, 15: 385-393, 1995.
54. Lazebmk, Y. A., Kaufmann, S. H., Desnoyers, S , Poiner, G G , and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
55. Quo, M. W., Mori, E , Xu, J. P., and Mori, T. Identification of Fas antigen associated with apoptotic cell death in murine ovary Biochem. Biophys. Res. Commun., 203: 1438-1446, 1994.
56. Tabibzadeh, S., Zupi, E., Babaknia, A., Liu, R., Marconi, D., and Romanini, C. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF α in human endometrium. Hum. Reprod., 10: 277-286, 1995
57. Suzuki, A , Enari, M., Eguchi, Y., Matsuzawa, A., Nagata, S., Tsujimoto, Y., and Iguchi, T. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J., 15: 211-215, 1996.
58. Robertson, M. J., Manley, T. J., Pichert, G., Cameron, C., Cochran, K. J., Levine, H., and Ritz, J. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells Leuk. Lymphoma, 17: 51-61, 1995.
59. Moller, P., Koretz, K., Leithauser, F., Bruderlein, S., Henne, C., Quentmeier, A., and Krammer, P H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57: 371-377, 1994.
60. Lebel, M , Bertrand, R., and Mesmasson, A. M. Decreased Fas antigen expression in testicular-tumor cell-lines derived from polyomavirus large T-antigen transgenic mice. Oncogene, 12: 1127-1135, 1996.
61. Natoli, G., Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I , Chinllo, P , Balsano, C , and Levrero, M. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 11: 1157-1164, 1995.
62. Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J , and Nagata, S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res , 215: 332-337, 1994
63. Zornig, M., Grzeschiczek, A., Kowalski, M. B , Hartmann, K. U , and Moroy, T. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV Oncogene, 10: 2397-2401, 1995.
64. Rouquet, N., Allemand, I., Molina, T., Bennoun, M., Briand, P., and Joulin, V. Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogene, 11: 1061-1067, 1995
65. McGahon, A. J., Nishioka, W. K., Martin, S. J , Mahboubi, A., Cotter, T. G., and Green, D R Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem., 270: 22625-22631, 1995
66. Tamura, T., Aoyama, N., Saya, H., Haga, H , Futami, S., Miyamoto, M., Koh, T., Ariyasu, T , Tachi, M , Kasuga, M , and Takahashi, R. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene, 11: 1939-1946, 1995
67. Matsue, H., Kobayashi, H , Hosokawa, T., Akitaya, T., and Ohkawara, A. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN γ-treated cultured keratinocytes. Arch. Dermatol. Res , 287: 315-320, 1995.
68. Nicholson, D. W , Ali, A., Thornberry, N. A , Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R , Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
69. Feamhead, H. O., Dinsdale, D., and Cohen, G. M An interleukin-1 β-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett., 375: 283-288, 1995.
70. Mashima, T., Naito, M , Fujita, N , Noguchi, K., and Tsuruo, T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun., 277: 1185-1192, 1995
71. Boudreau, N., Sympson, C J , Werb, Z , and Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix Science (Washington DC), 267: 891-893, 1995.